/BSTG
BSTG Stock - Biostage, Inc.
Healthcare|BiotechnologyOTC
$4.03+0.75%
+$0.03 (+0.75%) • Jul 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.2
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.43
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BSTG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.99 – $4.07
TARGET (TP)$4.63
STOP LOSS$3.71
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.97
52W High$9.00
52W Low$3.65
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-270,000 | $-24,000 | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-8,156,000 | $-9,093,000 | $-6,153,000 | $-8,636,000 | $-5,325,000 |
| Net Income | $-7,732,000 | $-9,022,000 | $-6,073,000 | $-7,978,000 | $-4,865,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.52 | $-0.67 | $-1.09 | $-0.74 | $-0.55 |
Company Overview
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BSTGBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.12
Q4 2023
EPS Surprise History
Q2 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 10, 2024 | — | — | — | — |
Q1 2024 | Mar 28, 2024 | — | — | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.12 | — | — |
Q3 2023 | Aug 2, 2023 | — | $-0.19 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.24 | — | — |
Q1 2023 | Mar 30, 2023 | — | $-0.12 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.10 | — | — |
Q3 2022 | Aug 4, 2022 | — | $-0.12 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.20 | — | — |
Q2 2022 | Apr 1, 2022 | — | $-0.55 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.08 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-0.04 | — | — |
Q2 2021 | May 24, 2021 | — | $-0.09 | — | — |
Q2 2021 | Apr 13, 2021 | — | $-0.11 | — | — |
Q4 2020 | Nov 13, 2020 | — | $-0.07 | — | — |
Q3 2020 | Aug 13, 2020 | — | $-0.14 | — | — |
Q2 2020 | May 14, 2020 | — | $-0.24 | — | — |
Q1 2020 | Mar 27, 2020 | — | $-0.21 | — | — |
Q4 2019 | Nov 12, 2019 | — | $-0.33 | — | — |
Q3 2019 | Aug 13, 2019 | — | $-0.37 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BSTG
What is BSTG's current stock price?
Biostage, Inc. (BSTG) is currently trading at $4.03 per share. The stock has moved +0.75% today.
What is the analyst price target for BSTG?
No analyst price targets are currently available for this stock.
What sector is Biostage, Inc. in?
Biostage, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is BSTG's market cap?
Biostage, Inc. has a market capitalization of $0.06 billion, making it a small-cap company.
Does BSTG pay dividends?
No, Biostage, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorETXPF
E-therapeutics Plc
$0.13
Mkt Cap: $0.1B
GDNSF
Goodness Growth Holdings, Inc.
$0.45
Mkt Cap: $0.1B
HRPMF
Herantis Pharma Oyj
$3.51
Mkt Cap: $0.1B
KDEVF
Karolinska Development AB (publ)
$0.26
Mkt Cap: $0.1B
MCIOF
MCI Onehealth Technologies Inc.
$0.55
Mkt Cap: $0.1B
MSSTF
Mindset Pharma Inc.
$0.54
Mkt Cap: $0.1B
MVRBF
Medivir AB (publ)
$0.82
Mkt Cap: $0.0B
NEVPF
Abliva AB (publ)
$0.03
Mkt Cap: $0.0B
ONPPF
Oncopeptides AB (publ)
$0.27
Mkt Cap: $0.1B
RLFTD
Relief Therapeutics Holding AG
$4.08
Mkt Cap: $0.0B
Explore stocks similar to BSTG for comparison